Anthem Biosciences Limited (NSE:ANTHEM)
809.85
+10.80 (1.35%)
May 13, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 448.75 billion as of May 13, 2026.
Market Cap
448.75B
Enterprise Value
439.54B
Revenue
20.02B
Ranking
n/a
PE Ratio
93.17
Stock Price
809.85
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 448.75B, an increase of 9.41%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 448.75B | 22.65% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 615.63B |
| OneSource Specialty Pharma | 210.39B |
| Concord Biotech | 122.81B |
| Blue Jet Healthcare | 85.08B |
| Supriya Lifescience | 56.88B |
| Zota Health Care | 43.50B |
| Dishman Carbogen Amcis | 29.36B |
| Panacea Biotec | 23.81B |